MX2018011193A - Proteinas derivadas de alfa-1-microglobulina novedosas y su uso. - Google Patents

Proteinas derivadas de alfa-1-microglobulina novedosas y su uso.

Info

Publication number
MX2018011193A
MX2018011193A MX2018011193A MX2018011193A MX2018011193A MX 2018011193 A MX2018011193 A MX 2018011193A MX 2018011193 A MX2018011193 A MX 2018011193A MX 2018011193 A MX2018011193 A MX 2018011193A MX 2018011193 A MX2018011193 A MX 2018011193A
Authority
MX
Mexico
Prior art keywords
derived proteins
novel alpha
microglobulin derived
microglobulin
alpha
Prior art date
Application number
MX2018011193A
Other languages
English (en)
Spanish (es)
Inventor
Wester Rosenlöf Lena
Edström Hägerwall Anneli
Åkerström Bo
Original Assignee
A1M Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A1M Pharma Ab filed Critical A1M Pharma Ab
Publication of MX2018011193A publication Critical patent/MX2018011193A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
MX2018011193A 2016-03-18 2017-03-17 Proteinas derivadas de alfa-1-microglobulina novedosas y su uso. MX2018011193A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201670158 2016-03-18
PCT/EP2017/056436 WO2017158181A1 (en) 2016-03-18 2017-03-17 Novel alpha-1-microglobulin derived proteins and their use

Publications (1)

Publication Number Publication Date
MX2018011193A true MX2018011193A (es) 2019-03-28

Family

ID=56080208

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011193A MX2018011193A (es) 2016-03-18 2017-03-17 Proteinas derivadas de alfa-1-microglobulina novedosas y su uso.

Country Status (14)

Country Link
US (1) US10981963B2 (enExample)
EP (1) EP3430032B1 (enExample)
JP (1) JP6976579B2 (enExample)
KR (1) KR102437662B1 (enExample)
CN (1) CN108779157B (enExample)
AU (1) AU2017235608B2 (enExample)
CA (1) CA3017836A1 (enExample)
EA (1) EA039776B1 (enExample)
ES (1) ES2896734T3 (enExample)
MX (1) MX2018011193A (enExample)
NZ (1) NZ746677A (enExample)
SG (1) SG11201807352XA (enExample)
WO (1) WO2017158181A1 (enExample)
ZA (1) ZA201805797B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3703729A1 (en) * 2017-11-03 2020-09-09 Guard Therapeutics International AB Use of alpha-1-microglobulin for protection of bone marrow cells
AU2024219294A1 (en) 2023-02-08 2025-07-10 Guard Therapeutics International AB Alpha-1-microglobulin derived peptide fragments and uses thereof
US12227343B2 (en) * 2023-03-17 2025-02-18 Blue Buffalo Enterpises, Inc. Retail ready opening feature for e-commerce carton

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2313106T3 (en) * 2008-07-18 2016-07-25 A1M Pharma Ab MEDICAL USE OF RADICAL binder and the antioxidant is alpha-1-microglobulin
US9758554B2 (en) * 2012-01-31 2017-09-12 Technische Universitaet Muenchen Muteins of α1m lipocalin and method of production therefor
PL2900254T3 (pl) * 2012-09-05 2017-02-28 A1M Pharma Ab Alfa-1 mikroglobulina do użycia w leczeniu chorób związanych z mitochondriami
WO2014047490A1 (en) * 2012-09-21 2014-03-27 Beintoo, S.P.A. Interactive experience fully contained within an expandalble embedded unit
US10226570B2 (en) * 2017-03-10 2019-03-12 Seton Healthcare Family Apparatus and method for temporarily securing a movable accessory device relative to a movable patient

Also Published As

Publication number Publication date
BR112018068522A2 (pt) 2019-01-22
US10981963B2 (en) 2021-04-20
WO2017158181A1 (en) 2017-09-21
EA039776B1 (ru) 2022-03-11
EA201892085A1 (ru) 2019-02-28
CA3017836A1 (en) 2017-09-21
CN108779157A (zh) 2018-11-09
ZA201805797B (en) 2022-03-30
ES2896734T3 (es) 2022-02-25
KR102437662B1 (ko) 2022-08-29
KR20180127411A (ko) 2018-11-28
NZ746677A (en) 2023-02-24
US20190161524A1 (en) 2019-05-30
CN108779157B (zh) 2022-12-30
SG11201807352XA (en) 2018-09-27
EP3430032A1 (en) 2019-01-23
EP3430032B1 (en) 2021-09-01
AU2017235608B2 (en) 2020-10-22
JP2019519466A (ja) 2019-07-11
JP6976579B2 (ja) 2021-12-08
AU2017235608A1 (en) 2018-10-18

Similar Documents

Publication Publication Date Title
ZA202107931B (en) Anti-tau antibodies and methods of use
CY1124106T1 (el) Συνθεσεις μεταφορεα-αντισωματος και μεθοδοι παρασκευης και χρησης αυτων
MX2024000300A (es) Anticuerpos antitau y metodos de uso.
MY182667A (en) Food compositions comprising one or both of recombinant beta-lactoglobulin protein and recombinant alphalactalbumin protein
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
PH12016501644A1 (en) Binding proteins and methods of use thereof
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
MX2019006330A (es) Anticuerpos anti-tau y metodos de uso.
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
MX375524B (es) Anticuerpos anti-axl.
MY176855A (en) Anti-jagged1 antibodies and methods of use
MX2023000204A (es) Variantes de proteinas de union al factor h y metodos de uso de estas.
GB201800334D0 (en) Modified protein
EA202091567A1 (ru) Химерные белки мти
NZ731491A (en) Cd83 binding proteins and uses thereof
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
PH12017502277A1 (en) Multi-specific binding proteins
PH12018550097A1 (en) Infant formula comprising human milk peptides
NZ746677A (en) Novel alpha-1-microglobulin derived proteins and their use